pharmacopeia

Coagulopathy

15 drugs3,082 FAERS reportsMedDRA PT
GET
/api/v1/reaction/coagulopathy
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D001778

Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.

Source: U.S. National Library of Medicine — MeSH (Blood Coagulation Disorders)

Drugs reporting Coagulopathy (15)

Share = reports listing this reaction ÷ total matched reports for the drug. means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Omidubicel15.6%
  2. 2Fomepizole105.4%
  3. 3Barium Iodate24.7%
  4. 4Sulconazole14.5%
  5. 5Difenoxin13.8%
  6. 6Ibutilide13.4%
  7. 7Tigecycline2043.4%
  8. 8Argatroban352.4%
  9. 9Idarucizumab312.2%
  10. 10Caffeic Acid12.0%
  11. 11Eravacycline41.8%
  12. 12Calaspargase Pegol121.8%
  13. 13Bivalirudin171.8%
  14. 14Dabigatran1,3811.8%
  15. 15Dabigatran Etexilate1,3811.8%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Blood Coagulation Disorders as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients